dobutamine has been researched along with bimakalim in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Criniti, A; del Monte, F; Ducouret, P; Iwashiro, K; Monti, F; Papalia, U; Picard, S; Puddu, PE; Rouet, R; Ruvolo, G; Tonelli, E | 1 |
| Campa, PP; Criniti, A; Iwashiro, K; La Francesca, S; Marino, B; Monti, F; Papalia, U; Picard, S; Puddu, PE; Ruvolo, G | 1 |
2 other study(ies) available for dobutamine and bimakalim
| Article | Year |
|---|---|
Protection of human myocardium in vitro by K(ATP) activation with low concentrations of bimakalim.
Topics: Adenosine Triphosphate; Adult; Benzopyrans; Dihydropyridines; Dobutamine; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; Heart Atria; Humans; Hypoxia; In Vitro Techniques; Isometric Contraction; Muscle Contraction; Myocardial Contraction; Myocardium; Oxygen; Potassium Channels; Time Factors | 1999 |
Adenosine triphosphate-dependent potassium channel modulation and cardioplegia-induced protection of human atrial muscle in an in vitro model of myocardial stunning.
Topics: Adenosine Triphosphate; Adult; Aged; Atrial Function, Right; Benzopyrans; Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Cardiotonic Agents; Cell Hypoxia; Dihydropyridines; Dobutamine; Female; Glyburide; Heart Arrest, Induced; Humans; In Vitro Techniques; Magnesium; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Sodium Chloride | 2000 |